Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma

R Motzer; N Tannir; D McDermott; Frontera O Arén; B Melichar; T Choueiri; E Plimack; P Barthélémy; C Porta; S George; T Powles; F Donskov; V Neiman; C Kollmannsberger; P Salman; H Gurney; R Hawkins; A Ravaud; M-O Grimm; S Bracarda; C Barrios; Y Tomita; D Castellano; B Rini; A Chen; S Mekan; M McHenry; M Wind-Rotolo; J Doan; P Sharma; H Hammers; B Escudier; Pirkko-Liisa Kellokumpu-Lehtinen

doi:10.1056/nejmoa1712126

Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma

R Motzer, N Tannir, D McDermott, Frontera O Arén, B Melichar, T Choueiri, E Plimack, P Barthélémy, C Porta, S George, T Powles, F Donskov, V Neiman, C Kollmannsberger, P Salman, H Gurney, R Hawkins, A Ravaud, M-O Grimm, S BracardaC Barrios, Y Tomita, D Castellano, B Rini, A Chen, S Mekan, M McHenry, M Wind-Rotolo, J Doan, P Sharma, H Hammers, B Escudier, Pirkko-Liisa Kellokumpu-Lehtinen

Department of Oncology

Research output: Contribution to journal › Article › Scientific › peer-review

1518 Citations (Scopus)

Original language	English
Pages (from-to)	1277-1290
Journal	NEW ENGLAND JOURNAL OF MEDICINE
Volume	387
Issue number	14
DOIs	https://doi.org/10.1056/nejmoa1712126
Publication status	Published - 2018
Publication type	A1 Journal article-refereed

Publication forum classification

Publication forum level 3

Access to Document

10.1056/nejmoa1712126

http://urn.fi/urn:nbn:fi:tuni-202002202251

Cite this

Motzer, R., Tannir, N., McDermott, D., Arén, F. O., Melichar, B., Choueiri, T., Plimack, E., Barthélémy, P., Porta, C., George, S., Powles, T., Donskov, F., Neiman, V., Kollmannsberger, C., Salman, P., Gurney, H., Hawkins, R., Ravaud, A., Grimm, M-O., ... Kellokumpu-Lehtinen, P-L. (2018). Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma. NEW ENGLAND JOURNAL OF MEDICINE, 387(14), 1277-1290. https://doi.org/10.1056/nejmoa1712126

Motzer, R ; Tannir, N ; McDermott, D ; Arén, Frontera O ; Melichar, B ; Choueiri, T ; Plimack, E ; Barthélémy, P ; Porta, C ; George, S ; Powles, T ; Donskov, F ; Neiman, V ; Kollmannsberger, C ; Salman, P ; Gurney, H ; Hawkins, R ; Ravaud, A ; Grimm, M-O ; Bracarda, S ; Barrios, C ; Tomita, Y ; Castellano, D ; Rini, B ; Chen, A ; Mekan, S ; McHenry, M ; Wind-Rotolo, M ; Doan, J ; Sharma, P ; Hammers, H ; Escudier, B ; Kellokumpu-Lehtinen, Pirkko-Liisa. / Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma. In: NEW ENGLAND JOURNAL OF MEDICINE. 2018 ; Vol. 387, No. 14. pp. 1277-1290.

@article{7164993fa27947f1acb80daeba87b6ab,

title = "Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma",

author = "R Motzer and N Tannir and D McDermott and Ar{\'e}n, {Frontera O} and B Melichar and T Choueiri and E Plimack and P Barth{\'e}l{\'e}my and C Porta and S George and T Powles and F Donskov and V Neiman and C Kollmannsberger and P Salman and H Gurney and R Hawkins and A Ravaud and M-O Grimm and S Bracarda and C Barrios and Y Tomita and D Castellano and B Rini and A Chen and S Mekan and M McHenry and M Wind-Rotolo and J Doan and P Sharma and H Hammers and B Escudier and Pirkko-Liisa Kellokumpu-Lehtinen",

year = "2018",

doi = "10.1056/nejmoa1712126",

language = "English",

volume = "387",

pages = "1277--1290",

journal = "NEW ENGLAND JOURNAL OF MEDICINE",

issn = "0028-4793",

number = "14",

}

Motzer, R, Tannir, N, McDermott, D, Arén, FO, Melichar, B, Choueiri, T, Plimack, E, Barthélémy, P, Porta, C, George, S, Powles, T, Donskov, F, Neiman, V, Kollmannsberger, C, Salman, P, Gurney, H, Hawkins, R, Ravaud, A, Grimm, M-O, Bracarda, S, Barrios, C, Tomita, Y, Castellano, D, Rini, B, Chen, A, Mekan, S, McHenry, M, Wind-Rotolo, M, Doan, J, Sharma, P, Hammers, H, Escudier, B & Kellokumpu-Lehtinen, P-L 2018, 'Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma', NEW ENGLAND JOURNAL OF MEDICINE, vol. 387, no. 14, pp. 1277-1290. https://doi.org/10.1056/nejmoa1712126

Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma. / Motzer, R; Tannir, N; McDermott, D; Arén, Frontera O; Melichar, B; Choueiri, T; Plimack, E; Barthélémy, P; Porta, C; George, S; Powles, T; Donskov, F; Neiman, V; Kollmannsberger, C; Salman, P; Gurney, H; Hawkins, R; Ravaud, A; Grimm, M-O; Bracarda, S; Barrios, C; Tomita, Y; Castellano, D; Rini, B; Chen, A; Mekan, S; McHenry, M; Wind-Rotolo, M; Doan, J; Sharma, P; Hammers, H; Escudier, B; Kellokumpu-Lehtinen, Pirkko-Liisa.

In: NEW ENGLAND JOURNAL OF MEDICINE, Vol. 387, No. 14, 2018, p. 1277-1290.

Research output: Contribution to journal › Article › Scientific › peer-review

TY - JOUR

T1 - Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma

AU - Motzer, R

AU - Tannir, N

AU - McDermott, D

AU - Arén, Frontera O

AU - Melichar, B

AU - Choueiri, T

AU - Plimack, E

AU - Barthélémy, P

AU - Porta, C

AU - George, S

AU - Powles, T

AU - Donskov, F

AU - Neiman, V

AU - Kollmannsberger, C

AU - Salman, P

AU - Gurney, H

AU - Hawkins, R

AU - Ravaud, A

AU - Grimm, M-O

AU - Bracarda, S

AU - Barrios, C

AU - Tomita, Y

AU - Castellano, D

AU - Rini, B

AU - Chen, A

AU - Mekan, S

AU - McHenry, M

AU - Wind-Rotolo, M

AU - Doan, J

AU - Sharma, P

AU - Hammers, H

AU - Escudier, B

AU - Kellokumpu-Lehtinen, Pirkko-Liisa

PY - 2018

Y1 - 2018

U2 - 10.1056/nejmoa1712126

DO - 10.1056/nejmoa1712126

M3 - Article

VL - 387

SP - 1277

EP - 1290

JO - NEW ENGLAND JOURNAL OF MEDICINE

JF - NEW ENGLAND JOURNAL OF MEDICINE

SN - 0028-4793

IS - 14

ER -